Annotated Medicine and Device Lists

Primaquine

Suspension 26.4mg (15mg base, as phosphate)/5ml Tablet 7.5 mg (as diphosphate) Tablet 15 mg (as diphosphate) Tablet 26.3mg (15 mg base) as phosphate Tablet 15 mg (phosphate) Tablet 5 mg (phosphate) Tablet 7.5 mg (phosphate) Tablet 5-15 mg Tablet 5 mg (as diphosphate)

This medicine is present in:

List	Section	Observation
Bolivia	LINAME 2011 - 2013	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	6.5.3.1. For curative treatment	Others observations: Only for use to achieve radical cure of P.vivax and P.ovale infections, given for 14 days.
PAHO Strategic Fund Medicine List	2.7.2. Anti-malarial	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	6.5.3.1. For curative treatment	Others observations: Only for use to achieve radical cure of P.vivax and P.ovale infections, given for 14 days.
PAHO Strategic Fund Medicine List	2.7.2. Anti-malarial	No observations

This medicine is present in:

List	Section	Observation
Bolivia	LINAME 2011 - 2013	No observations

This medicine is present in:

List	Section	Observation
Peru	6.5.3 Antimalarials	No observations
Colombia	03. Antimalarials	No observations
Cuba	6.1.1.2 Antipalúdicos	No observations

This medicine is present in:

List	Section	Observation
Peru	6.5.3 Antimalarials	No observations

This medicine is present in:

List	Section	Observation
Peru	6.5.3 Antimalarials	No observations

This medicine is present in:

List	Section	Observation
Ecuador	Essential Medicines List - Ecuador	No observations

This medicine is present in:

List	Section	Observation
PAHO Strategic Fund Medicine List	2.7.2. Anti-malarial	No observations

Information Resources: Primaquine

No information available